Tag - medicine-4

 
Menu
Search
 
November 22, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

MEDICINE 4

Japan Times
WORLD / Science & Health / ANALYSIS
Sep 30, 2022
Eisai drug's trial success raises hope for Alzheimer's prevention
Scientists have already begun to debate whether the benefit of the drug is robust enough, but to many researchers, the findings suggest that preventing decline altogether is possible.
Japan Times
COMMENTARY / World
Sep 30, 2022
Here’s who really needs the new COVID-19 booster
Instead of pushing everyone to get another COVID-19 vaccine, the CDC should be prioritizing older and unboosted people.
Japan Times
ASIA PACIFIC / Science & Health
Sep 30, 2022
A Chinese mRNA COVID vaccine gets its first approval — in Indonesia
Indonesia's food and drugs agency approved the use of Walvax Biotechnology's mRNA vaccine, which has been in development for more than two years.
Japan Times
JAPAN / Science & Health
Sep 29, 2022
Japan should consider allowing medical cannabis, health panel says
Japan should consider approving the import, manufacture and use of medicines derived from cannabis, a health ministry panel said.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Shionogi says COVID-19 pill trial shows reduction in symptoms
The drug met the trial's goal of reducing five key symptoms of the omicron variant within 72 hours of onset, the company said.
Japan Times
JAPAN / Science & Health
Sep 28, 2022
Alzheimer’s progression slowed by drug in major trial
The drug slowed cognitive decline in people with early Alzheimer's by 27% over 18 months when compared with a placebo using a common rating scale.
Japan Times
JAPAN
Sep 16, 2022
Japan to face a shortage of nearly 1 million medical and welfare staff in 2040
While 10.7 million such workers are projected to be necessary in 2040, only 9.74 million will be available, according to the 2022 white paper on health, labor and welfare.
Japan Times
ASIA PACIFIC
Sep 11, 2022
Food and medical shortages in locked-down region spur China apology
Reports of shortages and tough conditions in part of China's northern Xinjiang region bordering Kazakhstan have been swirling on Chinese social media for days.
Japan Times
COMMENTARY / World
Sep 4, 2022
Latest COVID-19 conundrum is when to get another shot
People's intuitions about timing their boosters don't always agree with the science. What will that mean for this fall's reformulated vaccines?
Japan Times
COMMENTARY / World
Sep 1, 2022
To fight monkeypox and other viruses, look harder in the sewers
Health authorities rely on a patchwork system for testing wastewater, often missing important information about virus outbreaks such as monkeypox.
Japan Times
WORLD / Science & Health
Aug 31, 2022
Race for monkeypox vaccines exposes global health inequality
Despite efforts to set up an equitable distribution mechanism for vaccines, some marginalized groups may face a longer wait than others.
Japan Times
BUSINESS / Companies
Aug 29, 2022
Olympus to sell microscope unit to Bain for $3 billion
In a statement, Olympus said the transfer to Bain would be in its best interest to allow the business to grow with more agile and flexible decision-making based on market needs.
Japan Times
ASIA PACIFIC
Aug 29, 2022
Chinese province bordering Beijing expands COVID-19 lockdown
Shijiazhuang, the provincial capital of China's Hebei province that borders Beijing, said mass testing will be done on residents in in four major downtown districts.
Japan Times
WORLD / Science & Health
Aug 17, 2022
Why a century-old vaccine offers new hope against pathogens
The B.C.G. tuberculosis vaccine may protect against COVID-19 and other infections by broadly bolstering the immune system.
Japan Times
COMMENTARY / World
Aug 12, 2022
We need to know why the omicron BA.5 wave is ebbing
Scientists are starting to figure out why infection rates rise and fall. But a collapse in COVID-19 testing will make it much harder to predict the next surge.
Japan Times
BUSINESS / Companies
Aug 9, 2022
Pfizer to buy Global Blood Therapeutics in $5.4 billion deal
Pfizer will gain Oxbryta, South San Francisco-based Global Blood's therapy for sickle-cell disease that sold about $195 million last year.
Japan Times
JAPAN
Aug 8, 2022
Pair of state-run Tokyo universities to consider merging
The two universities are aiming to integrate operations and apply for financial assistance from a planned state fund designed to support research institutes.
Two of America’s biggest debt holders are dumping Treasurys
The U.S. Treasury building in Washington. Investors in Japan and China sold a pile of U.S. debt in the last quarter, just before the U.S. presidential election.
Ishiba aggravates his own political failures with diplomatic faux pas
Prime Minster Shigeru Ishiba is greeted at the APEC summit in Lima by Canadian Prime Minister Justin Trudeau on Friday. The Japanese leader was criticized for remaining seated while meeting several world leaders at the event.
Japan's 3.31 million visitors in October set monthly record
Kiyomizu Temple in Kyoto in December 2023. Famous autumn leaf colors contributed to increased tourism demand last month from many markets across Asia, Europe and North America, the Japan National Tourism Organization has said.
Japan ranks last in romance satisfaction for second straight year
In a survey of 31 countries, Japan ranked last in terms of those who felt loved, with just 51% of respondents saying so.
Ruling coalition and DPP strike last-minute deal over economic policy
DPP policy chief Makoto Mahaguchi speaks at the party's policy gathering in Tokyo on Wednesday.
Japan, U.K. and Italy discuss inviting more countries to joint fighter project
A new concept model of a next-generation fighter jet to be jointly developed by Japan, Britain and Italy is on display in Farnborough, Hampshire, in July.
Haruki Murakami's 'The City and Its Uncertain Walls' gives deep deja vu
For “The City and Its Uncertain Walls,” translated into English by Philip Gabriel, Haruki Murakami confronts the ghosts who won't leave him alone.
Japanese expats in Asia find community through rugby
The Taiwan Fivewoods celebrate their victory at the 2023 Asian Japanese Rugby Cup in December of last year.
In Fukushima, a weekend of prose, poetry and translation
Aomori-based writer JJ Carter presented on tabletop gaming as creative inspiration for building characters and narratives.
For Dr. Nakamats, aging is just experience in action
Though he didn't win the recent gubernatorial election in Tokyo, the 96-year-old Dr. Nakamats' run was seen as inspirational in Japan's aging society.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?
By Kathryn Wortley

SUSTAINABLE JAPAN

SWCC keeps changing with keyword ‘new challenges’
SWCC keeps changing with keyword ‘new challenges’

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER